Reduced risk of brain cancer mortality from walking and running

Medicine and Science in Sports and Exercise

Volumn 46, Issue 5, 2014, Pages 927-932

  Williams, Paul T ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

moderate exercise; physical activity; Prevention; race; vigorous exercise

Indexed keywords

ADULT; BRAIN TUMOR; CAUCASIAN; ENERGY METABOLISM; ETHNOLOGY; FEMALE; GLIOMA; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK REDUCTION; RUNNING; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; WALKING;

ADULT; BRAIN NEOPLASMS; ENERGY METABOLISM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLIOMA; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK REDUCTION BEHAVIOR; RUNNING; WALKING;

EID: 84899650685     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0000000000000176     Document Type: Article

References (40)

1. Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev. 2009;30: 586-623.
2. Benson VS, Pirie K, Green J, Casabonne D, Beral V. Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer. 2008;99:185-90.
3. Borst SE, De Hoyos DV, Garzarella L, et al. Effects of resistance training on insulin-like growth factor-I and IGF binding proteins. Med Sci Sports Exerc. 2001;33(4):648-53.
4. Brenner AV, Linet MS, Shapiro WR, et al. Season of birth and risk of brain tumors in adults. Neurology. 2004;63:276-81.
5. Chambless LB, Parker SL, Hassam-Malani L, McGirt MJ, Thompson RC. Type 2 diabetes mellitus and obesity are independent risk factors for poor outcome in patients with high-grade glioma. J Neurooncol. 2012;106:383-9.
6. Derr RL, Ye X, Islas MU, Desideri S, Saudek CD, Grossman SA. Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma. J Clin Oncol. 2009;27:1082-6.
7. Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol. 2012; 14(5 Suppl):v1-49.
8. Edlinger M, Strohmaier S, Jonsson H, et al. Blood pressure and other metabolic syndrome factors and risk of brain tumour in the large population-based Me-Can cohort study. J Hypertens. 2012; 30:290-6.
9. Efird JT. Season of birth and risk for adult onset glioma. Int J Environ Res Public Health. 2010;7:1913-36.
10. Gariboldi MB, Ravizza R, Monti E. The IGFR1 inhibitor NVPAEW541 disrupts a pro-survival and pro-angiogenic IGFSTATHIF1 pathway in human glioblastoma cells. Biochem Pharmacol. 2010;80:455-62.
11. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res. 2003;35:694-704.
12. Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev. 2001;23:313-42.
13. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39(8):1423-34.
14. Hirano H, Lopes MB, Laws ER, et al. Insulin-like growth factor 1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas. Neuro Oncol. 1999; 1:109-19.
15. Inskip PD, Linet MS, Heineman EF. Etiology of brain tumors in adults. Epidemiol Rev. 1995;17:382-414.
16. Ish-Shalom D, Christoffersen CT, Vorwerk P, et al. Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia. 1997;40(2 Suppl):S25-S31.
17. Jones LW, Guill B, Keir ST, et al. Patterns of exercise across the cancer trajectory in brain tumor patients. Cancer. 2006;106: 2224-32.
18. Koistinen H, Koistinen R, Selenius L, Ylikorkala Q, Seppälä M. Effect of marathon run on serum IGF-I and IGF-binding protein 1 and 3 levels. J Appl Physiol. 1996;80:760-4.
19. Kushi LH, Doyle C, McCullough M, et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012;62:30-67.
20. Langley RR, Fidler IJ. The biology of brain metastasis. Clin Chem. 2013;59:180-9.
21. Matthews CE, Moore SC, George SM, Sampson J, Bowles HR. Improving self-reports of active and sedentary behaviors in large epidemiologic studies. Exerc Sport Sci Rev. 2012;40:118-26.
22. McGirt MJ, Chaichana KL, Gathinji M, et al. Persistent outpatient hyperglycemia is independently associate with decreased survival after primary resection of malignant brain astrocytomas. Neurosurgery. 2008;62:286-9.
23. Michaud DS, Bové G, Gallo V, et al. Anthropometric measures, physical activity, and risk of glioma and meningioma in a large prospective cohort study. Cancer Prev Res (Phila). 2011; 4:1385-92.
24. Moore SC, Rajaraman P, Dubrow R, et al. Height, body mass index, and physical activity in relation to glioma risk. Cancer Res. 2009; 69:8349-55.
25. Nemet D, Connolly PH, Pontello-Pescatello AM, et al. Negative energy balance plays a major role in the IGF-I response to exercise training. J Appl Physiol. 2004;96:276-82.
26. Prince SA, Adamo KB, Hamel ME, et al. A comparison of direct versus self-report measures for assessing physical activity in adults: a systematic review. Int J Behav Nutr Phys Act. 2008;5:56.
27. Ricard D, Idbaih A, Ducray F, LahutteM, Hoang-Xuan K, Delattre JY. Primary brain tumours in adults. Lancet. 2012;379(9830):1984-96.
28. Ruden E, Reardon DA, Coan AD, et al. Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma. J Clin Oncol. 2011;29:2918-23.
29. Ryan PD, Goss PE. The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer. Oncologist. 2008; 13:16-24.
30. Trojan J, Cloix JF, Ardourel MY, Chatel M, Anthony DD. Insulinlike growth factor type 1 biology and targeting in malignant gliomas. Neuroscience. 2007;145:795-811.
31. Wang H, Wang H, Shen W, et al. Insulin-like growth factorbinding protein 2 enhances GBM invasion by activating invasionenhancing genes. Cancer Res. 2003;63:4315-21.
32. Williams PT. Relationship of distance run per week to coronary heart disease risk factors in 8283 male runners. The National Runners' Health Study. Arch Intern Med. 1997;157:191-8.
33. Williams PT. Vigorous exercise, fitness and incident hypertension, high cholesterol, and diabetes. Med Sci Sports Exerc. 2008;40(6): 998-1006.
34. Williams PT. Advantage of distance-versus time-based estimates of walking in predicting adiposity. Med Sci Sports Exerc. 2012; 44(9):1728-37.
35. Williams PT. Non-exchangeability of running vs. other exercise in their association with adiposity, and its implications for public health recommendations. PLoS One. 2012;7:e36360.
36. Williams PT. Distance walked and run as improved metrics over time-based energy estimation in epidemiological studies and prevention; evidence from medication use. PLoS One. 2012;7:e41906.
37. Williams PT. Reduced risk of incident kidney cancer from walking and running. Med Sci Sports Exerc. 2014;46(2):312-7.
38. Williams PT, Thompson PD. Walking versus running for hypertension, cholesterol, and diabetes mellitus risk reduction. Arterioscler Thromb Vasc Biol. 2013;33:1085-91.
39. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4:278-99.
40. Wu W, Lamborn KR, Buckner JC, et al. Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma. Neuro Oncol. 2010;12:164-72.